We are live on ! Find out more
COLL icon

Collegium Pharmaceutical

158 hedge funds and large institutions have $898M invested in Collegium Pharmaceutical in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

42% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% less capital invested

Capital invested by funds: $900M → $898M (-$2.6M)

1.58% less ownership

Funds ownership: 109.35%107.77% (-1.6%)

3% less funds holding

Funds holding: 163158 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

88% less call options, than puts

Call options by funds: $2K | Put options by funds: $16K

Holders
158
Holders Change
-5
Holders Change %
-3.07%
% of All Funds
2.75%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
17
Increased
61
Reduced
43
Closed
20
Calls
$2K
Puts
$16K
Net Calls
-$14K
Net Calls Change
-$1M
Name Holding Trade Value Shares
Change
Change in
Stake
LSERS
101
Louisiana State Employees Retirement System
Louisiana
$376K +$2.31K +100 +0.6%
State Board of Administration of Florida Retirement System
102
State Board of Administration of Florida Retirement System
Florida
$373K +$15K +651 +4%
Fisher Asset Management
103
Fisher Asset Management
Washington
$357K
Envestnet Asset Management
104
Envestnet Asset Management
Illinois
$347K +$14.3K +621 +4%
VOYA Investment Management
105
VOYA Investment Management
Georgia
$337K -$26.9K -1,163 -8%
Allianz Asset Management
106
Allianz Asset Management
Germany
$337K +$330K +14,282 New
OPERF
107
Oregon Public Employees Retirement Fund
Oregon
$336K -$28.5K -1,232 -8%
MIM
108
MetLife Investment Management
New Jersey
$332K
DCM
109
Dupont Capital Management
Delaware
$327K
AQR Capital Management
110
AQR Capital Management
Connecticut
$322K +$21.5K +931 +7%
HSBC Holdings
111
HSBC Holdings
United Kingdom
$316K +$91.3K +3,950 +43%
New York State Teachers Retirement System (NYSTRS)
112
New York State Teachers Retirement System (NYSTRS)
New York
$311K +$45.9K +1,988 +18%
BNP Paribas Financial Markets
113
BNP Paribas Financial Markets
France
$290K +$131K +5,653 +85%
Marshall Wace
114
Marshall Wace
United Kingdom
$277K +$271K +11,718 New
GAM
115
Gotham Asset Management
New York
$268K +$262K +11,348 New
SAM
116
Shell Asset Management
Netherlands
$266K +$163K +7,040 +168%
IWM
117
IHT Wealth Management
Illinois
$255K +$300 +13 +0.1%
DekaBank Deutsche Girozentrale
118
DekaBank Deutsche Girozentrale
Germany
$252K
BJL
119
Brighton Jones LLC
Washington
$250K
MAM
120
Martingale Asset Management
Massachusetts
$237K -$153K -6,616 -40%
Susquehanna International Group
121
Susquehanna International Group
Pennsylvania
$230K +$225K +9,734 New
ECM
122
Everence Capital Management
Indiana
$226K +$221K +9,560 New
TRSOTSOK
123
Teachers Retirement System of the State of Kentucky
Kentucky
$225K
EB
124
Eastern Bank
Massachusetts
$221K
AA
125
AlphaCentric Advisors
Puerto Rico
$213K

COLL Hedge Fund Activity: Q2 2021 in Review

158 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q2 2021, worth a combined $898M — down 0.29% from $900M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of COLL and 17 opened new positions — a net loss of 3 holders — while 43 trimmed existing stakes and 61 added.

The largest buyer was Principal Financial Group, adding an estimated $7.48M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $17.5M sold.

  • 158 institutional investors held Collegium Pharmaceutical (COLL) as of Q2 2021, down from 163 in Q1 2021.
  • Funds reported $898M of Collegium Pharmaceutical stock for Q2 2021, down 0.29% quarter-over-quarter.
  • 17 funds opened new Collegium Pharmaceutical positions in Q2 2021 and 20 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q2 2021 was Principal Financial Group, an estimated $7.48M added.
  • The largest Collegium Pharmaceutical seller in Q2 2021 was Avidity Partners Management, an estimated $17.5M sold.

Based on aggregated 13F filings for Q2 2021.